What happens when you combine Singapore’s leading oncology expertise with Malaysia’s premier healthcare infrastructure? You get OncoCare Malaysia, a powerhouse new centre at Thomson Hospital Kota Damansara. Led by a team of specialists with over a century of collective experience across the UK, Singapore, and Malaysia, the centre is bridging the gap in advanced cancer care.
From AI-assisted radiotherapy to personalised immunotherapy, OncoCare is bringing “big-city” innovation to a local setting, giving Malaysian patients a fighting chance with the most sophisticated tools available today.
“The official launch today is more than the opening of a new facility. It marks our commitment to delivering cancer care that is precise, innovative, and supported by personalised treatment plans tailored to each patient. Our vision is to improve outcomes and bring new hope to those living with cancer,” shared Dr John Low Seng Hooi, Chief Executive Officer and Senior Consultant Clinical Oncologist of OncoCare Malaysia.
In his welcome speech, Dr John Low Seng Hooi, CEO and Senior Consultant Clinical Oncologist of OncoCare Malaysia, highlighted the centre’s commitment to delivering innovative, personalised cancer care to improve patient outcomes.
Expanding Access to Advanced Cancer Care
Building on its strong foundation in Singapore, OncoCare Malaysia extends access to advanced, specialist-led cancer care as part of Tamarind Health’s integrated regional network. The centre provides patients with convenient access to a full spectrum of oncology services, from early detection and diagnosis to treatment and survivorship support, all within one setting.
Cancer remains one of the top three causes of death in Malaysia, with breast, colorectal, and lung cancers being among the most common, according to the National Cancer Registry Report. OncoCare aims to bridge care gaps through timely screening, early intervention, and access to advanced therapies.
The 12,000-square-foot centre is designed as an integrated oncology ecosystem, housing 28 chemotherapy bays (22 chairs, 4 open bay beds, and 2 VIP rooms), 7 consultation clinics, and staffed by 5 resident oncologists and 2 visiting specialists in haematology and clinical oncology.
The newly launched oncology facility at OncoCare Malaysia is designed to provide patients with a comfortable and supportive treatment environment.
Led by an experienced team of resident oncologists with a combined 137 years of clinical experience and work experience in Malaysia, Singapore and the United Kingdom, OncoCare Malaysia provides comprehensive and coordinated care supported by Thomson Hospital’s surgical, diagnostic and radiotherapy facilities. This partnership ensures that every patient has access to a full continuum of care from diagnosis and treatment to survivorship and support services such as genetic counselling, nutrition and palliative care.
“For nearly two decades, Thomson Hospital Kota Damansara has earned a strong reputation as a leading multi-disciplinary hospital committed to delivering exceptional specialist care. In partnership with OncoCare Malaysia, we are elevating our oncology services to new heights, integrating advanced diagnostics, cutting-edge treatments and comprehensive patient support into one seamless care journey. This collaboration embodies our shared mission to drive better patient outcomes and reinforce Malaysia’s standing as a premier regional healthcare hub,” said Dr Siva Kumaran Jayaraman, Acting Chief Executive Officer of Thomson Hospital Kota Damansara.
From left to right: Dr Nur Adila Binti Mokhtar, Consultant Clinical Oncologist, OncoCare Malaysia; Dr Yugarajah Asokumaran, Consultant Medical Oncologist, OncoCare Malaysia; Mr Lim Eng Seng, Chief Strategy Officer, Tamarind Health, Ms Grace Chung, CEO, Tamarind Health, Yang Berhormat Puan Jamaliah binti Jamaluddin, Selangor State EXCO for Public Health & Environment; Dr John Low Seng Hooi, CEO & Senior Consultant Clinical Oncologist, OncoCare Malaysia, Dr Siva Kumaran, Acting CEO, Thomson Hospital Kota Damansara, Dr Matin Mellor Abdullah, Consultant Clinical Oncologist, OncoCare Malaysia; and Dr Ben Yap Beng Khiong, Consultant Clinical Oncologist, OncoCare Malaysia, officiated the launch of OncoCare Malaysia.
Innovation and Holistic Support
OncoCare Malaysia integrates advanced technologies and holistic care to support patients throughout every stage of their cancer journey. The centre offers molecular diagnostics, AI-assisted radiotherapy planning, and precision oncology approaches such as targeted therapy and immunotherapy. Beyond treatment, patients have access to a comprehensive support ecosystem that includes genetic counselling for patients and families, nutritional and psychosocial guidance, palliative care, and survivorship programmes.
“Our mission has always been clear – no patient should face cancer alone. With the official launch of OncoCare Malaysia, we are taking a meaningful step towards improving outcomes and bringing renewed hope to patients and their families,” added Dr John Low.
For more information, visit https://oncocare.my.
